Global CEA Testing Market: Growth Opportunities and Strategies

• Publication date: December 2011

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportuni...

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

In Vitro Diagnostic Industry in Europe

CEA TESTING MARKET: US, EUROPE, JAPAN
Test Volume, Sales Forecasts and Supplier Shares by Country
Table of Contents

I. Introduction
II. Worldwide Market and Technology Overview
A. Carcinoembrionic Antigen (CEA): Clinical Significance
and Laboratory Practices
B. Instrumentation Review And
Market Needs
1. Abbott AxSYM
2. Abbott IMx
3. Anagen AN2000/AuraFlex
4. Beckman Coulter Access
5. BioChem Pharma SR1
6. bioMerieux Vidas Series
7. Biotrol Systems 7000
8. J&J Diagnostics/Amersham Amerlite
9. J&J Diagnostics Vitros ECI
10. Olympus PK Series
11. Roche Cobas Core
12. Roche Elecsys
13. Roche ES 22
14. Roche ES 33
15. Roche ES 300/300 AL
16. Siemens ACS: 180
17. Siemens ACS: Centaur
18. Siemens ELISA Processor II/III
19. Siemens Immuno 1
20. Siemens/Opus/Plus/Magnum
21. Siemens Stratus
22. Tosoh AIA Series
23. Wallac/Pharmacia Delfia
C. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)Table of Contents (continued)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others
4. Biochips/Microarrays
5. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
6. Microcomputers and Automation
7. Artificial Intelligence
8. Flow Cytometry
9. Biosensors
D. Competing/Complementing Technologies
1. CTTable of Contents (continued)
2. MRI
3. NMR
4. PET
5.Photonics Spectroscopy
E. Personal Testing
III. France: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
V. Italy: Market Size, Growth and Major Suppliers’ Sales
and Market Shares

VI. Japan: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
VIII. U.K.: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
IX. U.S.A.: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
X. Design Criteria for Decentralized Testing Products
XI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established SuppliersTable of Contents (continued)
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIII. Competitive Profiles
- Abbott
- AdnaGen
- Ambrilia Biopharma
- AMDL
- Beckman Coulter
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CanAG Diagnostics
- CeMines
- Cepheid
- Correlogic Systems
- Dako
- Decode
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Enterix
- Enzo Biochem
- Epigenomics
- Exact Sciences
- FujirebioTable of Contents (continued)
- Gen-Probe
- Guided Therapeutics
- Hologic
- Ipsogen
- J&J Diagnostics
- Kreatech
- Kyowa Medex
- Mackay Life Sciences
- Matritech
- Myriad Genetics
- OncoLab
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac
- Zila
CEA TESTING MARKET: US, EUROPE, JAPAN
Test Volume, Sales Forecasts and Supplier Shares by Country

List of Tables

Major Companies Developing or Marketing CEA Tests
France
CEA Test Volume and Diagnostics Sales by Market
Segment
France
CEA Testing Market by Major Supplier
Germany
CEA Test Volume and Diagnostics Sales by Market
Segment
Germany
CEA Testing Market by Major Supplier
Italy
CEA Test Volume and Diagnostics Sales by Market
Segment
Italy
CEA Testing Market by Major Supplier
Japan
CEA Test Volume and Diagnostics Sales by Market
Segment
Japan
CEA Testing Market by Major Supplier
Spain
CEA Test Volume and Diagnostics Sales by Market
SegmentList of Tables (continued)
Spain
CEA Testing Market by Major Supplier
U.K.
CEA Test Volume and Diagnostics Sales by Market
Segment
U.K.
CEA Testing Market by Major Supplier
U.S.A.
CEA Test Volume and Diagnostics Sales by Market
Segment
U.S.A.
CEA Testing Market by Major Supplier